Home/Filings/4/0001282930-04-000003
4//SEC Filing

BIOCRYST PHARMACEUTICALS INC 4

Accession 0001282930-04-000003

$BCRXCIK 0000882796operating

Filed

Apr 28, 8:00 PM ET

Accepted

Apr 29, 2:57 PM ET

Size

12.2 KB

Accession

0001282930-04-000003

Insider Transaction Report

Form 4
Period: 2004-04-27
BUGG CHARLES E
DirectorChairman
Transactions
  • Sale

    Common Stock

    2004-04-27$9.55/sh7,500$71,65752,557 total
  • Sale

    Common Stock

    2004-04-27$9.55/sh10,000$95,50060,057 total
  • Award

    Common Stock

    2004-04-27$4.63/sh+100,000$462,500137,557 total
  • Exercise/Conversion

    Stock Option

    2004-04-27100,000558,901 total
    Exercise: $4.63From: 1995-12-09Exp: 2004-12-08Common Stock (100,000 underlying)
  • Sale

    Common Stock

    2004-04-27$9.50/sh67,500$641,25070,057 total
Holdings
  • Common Stock

    (indirect: By Partnership)
    73,138

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000882796

Filing Metadata

Form type
4
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 2:57 PM ET
Size
12.2 KB